Choledocholithiasis
Conditions
Brief summary
Laboratory change induced by common bile duct (CBD) stone is in general observed as the higher elevation of alkaline phosphatase (ALP) and gamma-glutamyl transpeptideas (ɤ-GT), in comparison to those of aspartate aminotransferase (AST) and alanine aminotransferase (ALT). However, some patients with CBD stone show the marked increased level of aminotransferase, which sometimes leads to misdiagnose those as liver disease caused by viral hepatitis, ischemia, and drug toxicity. The aim of this study is to investigate the clinicopathologic features of patients with CBD stones with the high level of aminotransferase in serum.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
1. patients were diagnosed with CBD stone under endoscopic retrograde cholangiopancreatography (ERCP) 2. patients showing above 400 IU/L of aminotransferase when at the first admitted into hospital and the control groups is the patients displaying normal AST and ALT.
Exclusion criteria
* 1\. underlying hepatobiliary disease 2. alcoholics 3. cholangitis
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| clinicopathologic features of patients with CBD stones with the high level of aminotransferase | 1year | lab finding, radiologic images, and findings under ERCP such as CBD diameter, CBD stone diameter, CBD stone number, periampullary diverticulum. |